These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 15828305)

  • 21. Monitoring of minimal residual disease in acute myeloid leukemia.
    Kern W; Haferlach C; Haferlach T; Schnittger S
    Cancer; 2008 Jan; 112(1):4-16. PubMed ID: 18000811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of minimal residual disease in acute myeloid leukemia.
    Kern W; Schoch C; Haferlach T; Schnittger S
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):283-309. PubMed ID: 16213150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the detection of bone marrow micrometastases: A promising area for research or just another false hope? A review of the literature.
    Athanassiadou P; Grapsa D
    Cancer Metastasis Rev; 2006 Dec; 25(4):507-19. PubMed ID: 17160555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of micrometastatic disease in bone marrow: is it ready for prime time?
    Janni W; Rack B; Lindemann K; Harbeck N
    Oncologist; 2005 Aug; 10(7):480-92. PubMed ID: 16079315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and monitoring of minimal residual disease by quantitative real-time PCR.
    Schüler F; Dölken G
    Clin Chim Acta; 2006 Jan; 363(1-2):147-56. PubMed ID: 16154122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The prognostic significance of P-glycoprotein in children with acute lymphoblastic leukemia and neuroblastoma].
    De Moerloose B
    Verh K Acad Geneeskd Belg; 2005; 67(1):45-54. PubMed ID: 15828306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor cells and bone marrow micrometastasis.
    Alix-Panabières C; Riethdorf S; Pantel K
    Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micrometastases in neuroblastoma: are they clinically important?
    Burchill SA
    J Clin Pathol; 2004 Jan; 57(1):14-20. PubMed ID: 14693828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of minimal residual disease in children with neuroblastoma].
    De Moerloose B; Swerts K
    Verh K Acad Geneeskd Belg; 2005; 67(1):33-44. PubMed ID: 15828305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting minimal residual disease in neuroblastoma patients-the present state of the art.
    Beiske K; Ambros PF; Burchill SA; Cheung IY; Swerts K
    Cancer Lett; 2005 Oct; 228(1-2):229-40. PubMed ID: 15951104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal residual marrow disease: detection and significance of isolated tumour cells in bone marrow.
    Iorgulescu DG; Kiroff GK
    ANZ J Surg; 2001 Jun; 71(6):365-76. PubMed ID: 11409023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and treatment of minimal residual disease in high-risk neuroblastoma.
    Reynolds CP
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():56-66. PubMed ID: 15125707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Micrometastases in pediatric oncology].
    Bernard F; Aerts I; Margueritte G; Astruc J
    Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.